| Old Articles: <Older 6121-6130 Newer> |
 |
The Motley Fool January 8, 2010 Brian Orelli |
Heartburn Relieved ... for Now AstraZeneca settles its patent dispute with Teva.  |
The Motley Fool January 8, 2010 Brian Orelli |
Pfizer's Having a Garage Sale Rather than sending its unwanted drugs to the trash bin, the giant drugmaker is striking deals with its comrades to take them off its hands.  |
BusinessWeek January 7, 2010 Catherine Arnst |
Hospitals: Radical Cost Surgery A hospital that slashes costs - and delivers high-quality care as it innovates? Yes, it exists.  |
BusinessWeek January 7, 2010 Capell & Doherty |
What Novartis Sees in Eye Care Novartis CEO Dan Vasella's $50 billion bet on Alcon could help insulate it from the vagaries of the drug business.  |
The Motley Fool January 7, 2010 Brian Orelli |
Pfizer Strides Farther Into Generics Pfizer's new look might be just what the doctor ordered.  |
The Motley Fool January 7, 2010 Brian Orelli |
Warning: Potential Anemic Growth Ahead Anemia-drug makers get more scrutiny from the FDA.  |
Chemistry World January 6, 2010 Ned Stafford |
UK libel laws threaten scientific debate A libel lawsuit brought by GE Healthcare has succeeded in silencing an eminent Danish radiologist who questioned the safety of one of the firm's drugs, but the firm is now being accused by some in the scientific community of trying to stifle legitimate scientific discussion.  |
The Motley Fool January 6, 2010 Brian Orelli |
Gilead Goes It Alone ... for Now Investors jump for joy as Gilead Sciences announces what on the surface sounds like rather inconsequential data.  |
The Motley Fool January 5, 2010 Brian Orelli |
A Deal Manufactured by Necessity Genzyme gets some help from a new friend.  |
The Motley Fool January 5, 2010 Brian Orelli |
Lilly's Effient: Cheap Enough, for Now In order to justify the use of Effient, Eli Lilly is touting a study published in today's Circulation demonstrating the cost effectiveness of Effient over Plavix.  |
| <Older 6121-6130 Newer> Return to current articles. |